Dear Prospective Industry Partner,
As organizers of the Cancer Metastasis through the Lymphovascular System: Biology & Treatment, 7th International Symposium, April 20-22, 2017 at the Holiday Inn Golden Gateway, San Francisco, California, we invite your participation and support. This is a very exciting time to be involved in cancer research! The 7th iteration of the Symposium brings together international experts in oncology, immunobiology, pharmacology, molecular biology and molecular imaging to discuss preclinical, translational and clinical advances in diagnosing, treating and preventing cancer metastasis as we enter the era of precision medicine.
Target Audience: Based on the attendance history we anticipate 200-300participants, a collegial atmosphere with ample opportunity to network and meet with every attendee with a potential interest in your product or services. These attendees will be primarily physicians (65%) specializing in surgery, oncology, molecular imaging, plastic surgery, radiation oncology, hematology, thoracic medicine with the remainder a mixture of predominately PhD/scientists from both academia and biotechnology as well as a smaller groups of attendees who are in training, regulatory or from industry.
Most of the Live Presentations (based on individual speaker’s permission) will be included in a Virtual Meeting format on the Symposium Website and made available to attendees following the Congress as well as to researchers and clinicians around the world for years to come. The industry sponsored sessions will all be available on the Virtual Meeting on an open access basis.
Please review the program and contact Joan Oefner if the international, multi-disciplinary participants of this CME Program are potential customers for your company. We are happy to customize a sponsorship package based on your company’s specific needs and requirements.
The Symposium is sponsored by the Sentinel Node Oncology Foundation, a 501( c )( 3 ) non-profit organization founded in 2003 to advance the care and treatment of patients with solid cancer and to help develop new preventative strategies, diagnostics, and treatments.
The Organizing Committee is building a program that follows the journey of cancer metastasis from detection at the molecular level to genomic identification to precision treatment and survival. It is the goal of this biennial symposium to bring together basic scientists, oncologists, surgeons, and radiologists from around the world, resulting in a cross-fertilization of ideas that will enhance the translation of basic science into clinical application—and challenge basic scientists with clinical issues.
In addition to plenary sessions with distinguished guest faculty, time will be allotted for integrated oral abstract presentations and e-Poster sessions peer-selected from submitted abstracts by attendees, young investigators and trainees. Select members of the Organizing Committee will chair Mini-Symposia on topics such as:
- Cancer Metastasis Models from Melanoma, Breast Cancer, Gynecological Cancer and Others
- Molecular Targeting and Immunotherapy Based on Immune Checkpoint Inhibition
- Molecular Imaging of Cancer Metastasis which will focus on the newest advances being made, future directions and translational challenges
The theme of our Symposium is to track the single cell in our body, that has become a mutant cell, which proliferates with resultant mutants being selected to become the fittest clone to spread through the lymphovascular system using the sentinel lymph node as the primary gateway to distant sites to cause devastation to the body. It is a journey that we have to understand from a molecular level so that it can be stopped before the mutants go awry.
A separate ballroom has been reserved for the Posters, commercial exhibits and industry sponsored breakfast and lunch symposia on the most significant cancers or oncology topics related to late breaking results from clinical trials in cancer therapy, for maximum exposure to the participants and will be open throughout the 3 days of the Symposium.
We are confident that this 3 day CME accredited activity in San Francisco will make a significant impact by updating the oncologists with the latest development in cancer therapy and bringing the clinical relevance of cancer metastasis to the basic scientists.
In addition to our regular sessions, this year’s program will feature a post meeting virtual meeting on cancermetastasis.org, which will extend the life of the Symposium.
Thank you for your consideration and we look forward to seeing you in San Francisco!
Stanley P. L. Leong, MD, FACS
President, Sentinel Node Oncology Foundation
Chief of Cutaneous Oncology
Associate Director of the Melanoma Program
Center for Melanoma Research and Treatment
California Pacific Medical Center
California Pacific Medical Center Research Institute
For more information on how to support Cancer Metastasis through the Lymphovascular System: Biology & Treatment, 7th International Symposium, please contact the Symposium Manager, Joan Oefner by Email or fill out the form below: